SCHEMBL3017210

SCHEMBL3017210

CN1CCC(Nc2ncc(F)cc2C(=O)N[C@H]2CC[C@@H](NC(=O)O)CC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYRO3 Q06418 9/20 0.48
FLT3 P36888 3/20 0.48
MERTK Q12866 3/20 0.48
GAS6 Q14393 2/20 0.48
SELP P16109 5/20 0.47
AURKA O14965 5/20 0.47
CHEK1 O14757 3/20 0.47
IKBKB O14920 3/20 0.47
PAK4 O96013 3/20 0.47
CHEK2 O96017 3/20 0.47
ABL1 P00519 3/20 0.47
EGFR P00533 3/20 0.47
INSR P06213 3/20 0.47
LCK P06239 3/20 0.47
FGFR1 P11362 3/20 0.47
CSNK2A2 P19784 3/20 0.47
CCNA2 P20248 3/20 0.47
CDK2 P24941 3/20 0.47
MAPK1 P28482 3/20 0.47
AKT1 P31749 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3017215 1.00 TYRO3 (0.48) TYRO3FLT3MERTKGAS6SELP
SCHEMBL16087253 0.89 TYRO3 (0.46) TYRO3FLT3MERTKGAS6SELP
SCHEMBL10271650 0.86 SSTR4 (0.48) TYRO3FLT3MERTKGAS6SELP
SCHEMBL871647 0.85 TYRO3 (0.47) TYRO3FLT3MERTKGAS6SELP
SCHEMBL871646 0.85 TYRO3 (0.47) TYRO3FLT3MERTKGAS6SELP
SCHEMBL870326 0.85 SSTR4 (0.46) TYRO3FLT3MERTKGAS6SELP
SCHEMBL4110540 0.84 MCHR1 (0.40) TYRO3FLT3MERTKGAS6MAP4K4
SCHEMBL4110544 0.84 MCHR1 (0.40) TYRO3FLT3MERTKGAS6MAP4K4
SCHEMBL4107426 0.80 HPGD (0.40) TYRO3MERTKMAPK1MAP4K4MCHR1
SCHEMBL4107432 0.80 HPGD (0.40) TYRO3MERTKMAPK1MAP4K4MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100204203-A1 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors ALCON RESEARCH, LTD. 2010-08-12 US disclosed
US-20090124596-A1 Chemical Compounds 637 ALCON RESEARCH, LTD. 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124596-A1 Chemical Compounds 637 PDE4A, PDE4B, PDE3B TYRO3 3353/4885FLT3 3213/4885MERTK 3865/4885
US-20100204203-A1 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors PDE4A, PDE4B, PDE5A TYRO3 3522/4885FLT3 2839/4885MERTK 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.